June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Refractory Esophageal Varices: Strategies Compared

A new review outlines updated strategies for managing refractory esophageal varices, comparing international guidelines and highlighting minimally invasive options such as embolization and stenting when endoscopic methods fail.

Conexiant

June 27, 2025

MASLD Linked to Sudden Hearing Loss

New research links a common metabolic liver condition in older adults to elevated risk of sudden hearing loss, highlighting potential implications for screening and prevention.

Conexiant

June 24, 2025

Dermatologists Show Lowest Turnover Intent of All Specialists

AMA data show only 19.9% of dermatologists plan to leave their current positions, compared with 40.6% of anesthesiologists.

Conexiant

June 24, 2025

Blood Test Predicts Liver Transplant Failure

A new blood test analyzing cell-free DNA methylation patterns can identify the type and source of liver transplant injuries weeks before clinical diagnosis, potentially reducing reliance on biopsies.

Conexiant

June 11, 2025

8-Week Oral Therapy Approved for Acute HCV

The FDA has approved Mavyret for the treatment of acute hepatitis C, offering physicians a pangenotypic, 8-week oral regimen for early intervention.

Conexiant

June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant

April 26, 2024

Lack of Widespread Adoption of Nonstigmatizing Language on Liver Transplant Center Websites

Stigmatizing language on transplant websites may deter patients with alcohol use disorder and alcohol-associated liver disease from seeking necessary medical care.

Conexiant

May 01, 2024

Chronic Liver Disease in Latinx Pediatric Patients: Risk Factor Potentially Identified as Cases Rise

Investigators may have uncovered a new factor contributing to the rising incidence of metabolic dysfunction–associated steatotic liver disease among Latinx pediatric patients.

Conexiant